Figure 4.
Log-rank analysis of progression-free survival (PFS) and overall survival (OS) for patients with (M) and without (WT) KIT L541 variant in phase II Desminib trial.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.